Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Rossi Sebastiano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|July 27, 2019
Targeting Long Chain Acyl-CoA Synthetases for Cancer TherapyMatteo Rossi Sebastiano, Georgia Konstantinidou
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Drug Discovery Today|August 18, 2024
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegiasMatteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
ACS Medicinal Chemistry Letters|July 15, 2021
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral DrugsGiuseppe Ermondi, Diego Garcia Jimenez, Matteo Rossi Sebastiano, et al.
ADMET & DMPK|March 18, 2022
Are we ready to design oral PROTACs®?Diego Garcia Jimenez, Matteo Rossi Sebastiano, Giulia Caron, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
BBB-Permeable PROTACs: Where Do We Stand?Serena Francisco, Giulia Apprato, Matteo Rossi Sebastiano, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation ComplexesPaolo Rossetti, Giulia Apprato, Giulia Caron, et al.
Medicinal Research Reviews|March 16, 2026
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target-Driven Drug DiscoveryMatteo Rossi Sebastiano, Giulia Apprato, Serena Francisco, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2022
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagyMaria Saliakoura, Matteo Rossi Sebastiano, Ioanna Nikdima, et al.
Journal of Medicinal Chemistry|September 12, 2022
Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5Matteo Rossi Sebastiano, Diego Garcia Jimenez, Maura Vallaro, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|July 27, 2019
Targeting Long Chain Acyl-CoA Synthetases for Cancer TherapyMatteo Rossi Sebastiano, Georgia Konstantinidou
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Drug Discovery Today|August 18, 2024
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegiasMatteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
ACS Medicinal Chemistry Letters|July 15, 2021
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral DrugsGiuseppe Ermondi, Diego Garcia Jimenez, Matteo Rossi Sebastiano, et al.
ADMET & DMPK|March 18, 2022
Are we ready to design oral PROTACs®?Diego Garcia Jimenez, Matteo Rossi Sebastiano, Giulia Caron, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
BBB-Permeable PROTACs: Where Do We Stand?Serena Francisco, Giulia Apprato, Matteo Rossi Sebastiano, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation ComplexesPaolo Rossetti, Giulia Apprato, Giulia Caron, et al.
Medicinal Research Reviews|March 16, 2026
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target-Driven Drug DiscoveryMatteo Rossi Sebastiano, Giulia Apprato, Serena Francisco, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2022
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagyMaria Saliakoura, Matteo Rossi Sebastiano, Ioanna Nikdima, et al.
Journal of Medicinal Chemistry|September 12, 2022
Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5Matteo Rossi Sebastiano, Diego Garcia Jimenez, Maura Vallaro, et al.
Pageof 3